AI assistant
ASTEC LIFESCIENCES LIMITED Call Transcript 2021
61682_rns_2021-01-22_74ec0824-c83b-4b81-9af6-ab0f5b485997.pdf
Call Transcript
Open in viewerOpens in your device viewer
Date: 22nd January, 2021
To, To,
BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400 051
Ref.: BSE Scrip Code No. "533138" Ref.: "ASTEC"
Subject: Intimation of Schedule of Conference Call with Investors & Analysts to be held on Wednesday, 27th January, 2021 at 3.00 p.m.
Dear Sir / Madam,
We have attached herewith a communication on the Schedule of Conference call with the Investors and Analysts to be held on Wednesday, 27th January, 2021 at 3.00 p.m. IST.
The aforesaid information is also being hosted on the website of the Company viz., www.astecls.com.
Please take the same on your records.
Thanking you,
Yours sincerely, For Astec LifeSciences Limited
TEJASHREE ROHAN PRADHAN
Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167)
Digitally signed by TEJASHREE ROHAN PRADHAN DN: c=IN, o=Personal, 2.5.4.20=d7353bf95b7d8de2bb8a40acecbf3d366b9b 547485e521d767e1a5353c31c3a0, postalCode=400606, st=MAHARASHTRA, serialNumber=cc444393f2150dc819f3d8164db345c5 55b40cb184b6ae8611cda7b9d64587a7, cn=TEJASHREE ROHAN PRADHAN, l=THANE, pseudonym=22b31a79fb934b36b4be2e85835a9a14 Date: 2021.01.22 20:16:45 +05'30'
Astec LifeSciences Limited's
Q3FY21 Conference call Wednesday, January 27, 2021 at 3:00 PM IST
Astec LifeSciences, a manufacturer of wide range of agrochemicals active ingredients and intermediate products and a 62.33% subsidiary of Godrej Agrovet, will organize its earning's conference call for investors and analysts on Wednesday, January 27, 2021 at 3:00 PM IST.
The senior management team at Astec LifeSciences will initiate the conference call with a brief discussion on Q3 and 9MFY21 performance, followed by an interactive Question & Answer session.
| Time | 3:00 PM IST 5:30PM SG/HK 9:30AM UK 4:30AM US (ET) |
|---|---|
| Conference dial –in – Numbers | +91 22 6280 1145 (Main access number) |
| +91 22 7115 8046 (Standby access number) | |
| Conference dial-in – International Access(Toll- free Number) | Singapore: 800 101 2045 |
| Hong Kong : 800 964 448 | |
| UK: 0 808 101 1573 | |
| USA: 1 866 746 2133 | |
| Pre-registration | To enable participants to connect to the conference call without havingto wait for an operator, please register at the below mentioned link: |
| You will receive dial in numbers, passcode and a pin for the concall onthe registered email address provided by you. Kindly dial into the call onthe Conference Call date and use the passcode & pin to connect to call |
Details of the conference call are as under:
Please dial in 10 minutes prior to the scheduled call to ensure you are connected well in time.
About Astec LifeSciences Ltd:
Astec LifeSciences Ltd. is engaged in the manufacture and sale of agrochemical active ingredients (technical), bulk and formulations, intermediate products. The company has its manufacturing locations mainly at Mahad (Raigad, Maharashtra).
With over two decades of experience in development and production of selected chemicals, Astec has forged enduring relationships with its customers all over the world. The Company sells its products in India as well as exports them to approximately 24 countries.
In August 2015, erstwhile promoters of Astec LifeSciences sold 45.29% of its paid-up equity shares to Godrej Agrovet. As on December 2020, Godrej Agrovet holds 62.33% stake in Astec LifeSciences.
For further information you may log on to http://www.astecls.com/ or please contact us on:
| Chhavi Agarwal, CFA | Ankur Periwal, CFA, FRM |
|---|---|
| Investor Relations | (SVP – Spec Chem & Midcaps) |
| Godrej Agrovet Ltd. | Axis Capital Limited |
| Godrej One, 3rd Floor, | Direct: +91 22 4325 1149 |
| Phone No. 91 22 2519 4646 | Mobile: +91 98204 16359 |
| Email id: [email protected] | Email: [email protected] |
DISCLAIMER:
Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in political and economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Astec LifeSciences Limited will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
---